You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健倍苗苗(02161.HK)擬3800萬港元收購健福堂中醫集團全部股權

格隆匯6月16日丨健倍苗苗(02161.HK)公告,於2025年6月16日,買方(公司的間接全資附屬公司)與賣方訂立買賣協議,據此,買方有條件同意收購而賣方有條件同意出售銷售股份(即目標公司健福堂中醫集團有限公司全部已發行股本),根據買賣協議的條款及條件,總代價爲3800萬港元(可予調整)。

目標公司爲一間於香港註冊成立的有限公司。目標公司及其附屬公司主要從事提供中醫診症服務及銷售健康產品。

收購事項爲集團帶來策略性機遇,以把握對傳統中藥及預防性健康解決方案持續增加的需求。此舉使集團能透過目標集團廣泛的診所網絡,擴展濃縮中藥顆粒的分銷基礎,並釋放其品牌中藥產品組合的增長潛力。

集團預期收購事項將帶來可持續的收益及盈利增長,並預期利用目標集團業務的互補優勢帶來顯著的協同效應,包括直接獲取既有的客戶羣、爲推介集團品牌中藥提供直接渠道,以及提高本地市場的品牌認可度。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account